Sara Stephania Salazar-López

Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle

F. Folli, R. Guardado-Mendoza, M. L. Evia-Viscarra, 2021, Scientific Reports.

The combination of Linagliptin, Metformin and Lifestyle Modification to prevent Type 2 Diabetes (PRELLIM). A randomized clinical trial.

E. Suárez-Pérez, R. Guardado-Mendoza, M. L. Evia-Viscarra, 2019, Metabolism: clinical and experimental.